Spots Global Cancer Trial Database for EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
Official Title: Endoscopic Ultrasound-guided Fine-needle Injection for Nonfunctional Pancreatic Neuroendocrine Tumors: a Prospective Multicenter Study
Study ID: NCT05566093
Study Description
Brief Summary: The current study aims to access the feasibility, safety, and efficacy of EUS-FNI for nonfunctional pNETs
Detailed Description: The management of nonfunctional pancreatic neuroendocrine tumors (NF-pNETs) remains controversial. In general, surgical resection is the standard treatment for NF-pNETs. However, the incidence of postoperative adverse events of surgical resection is relatively high. Recently, several studies have revealed that endoscopic ultrasonography (EUS)-guided fine-needle injection (EUS-FNI) with ethanol or lauromacrogol may offer an effective treatment for pNETs. Therefore, a multicenter prospective study is being conducted to further identify the efficacy and safety of EUS-FNI for NF-pNETs.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
Contact Details
Name: Shanyu Qin, MD,Ph.D
Affiliation: First Affiliated Hospital of Guangxi Medical University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
